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Abstract
Background. Obesity is frequently referred to as an independent risk factor for high blood pressure and hyperten-
sion is very prevalent among obese people. The aims of this study were: to compare office-based and 24 h blood 
pressure (BP) and its circadian pattern between lean and obese women; to study correlations between BP, insulin 
resistance (IR) and markers of subclinical inflammation/early atherosclerosis.
Material and methods. Eighty-eight lean and 107 otherwise healthy obese women were characterized for anthropo-
metrics, BP (office-based determinations and 24 h ABPM) and for glucose, insulin, triglycerides, inteleukin 6 (IL-6), 
tumor necrosis factor alpha (TNF-a), high-sensitivity C reactive protein (hs-CRP), retinol-binding protein 4 (RBP-4), 
leptin, adiponectin, resistin, monocyte chemoattractant protein 1 (MCP-1), intercellular adhesion molecule 1 
(ICAM-1), and vascular-cellular adhesion molecule 1 (VCAM-1). Insulin resistance was determined by homeostasis 
model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), and 
McAuley indexes (also Matsuda in obese).
Results. Obese group presented higher office-based systolic/diastolic BP, systolic ambulatory blood pressure moni-
toring (ABPM), and more non-dippers. HOMA-IR and body fat was correlated to systolic (r2 = 0.176) and glucose 
to diastolic (p = 0.008; r = 0.256) ABPM. Age, QUICKI, and TNF-a was correlated with dipping (r2 = 0.172); adi-
ponectin, age, BMI, and glucose to systolic (r2 = 0.226) and diastolic (r2 = 0.215) office-based BP. Concerning lean 
women, MCP-1 was associated with diastolic ABPM (p = 0.013; r = 0.267). Systolic office-based BP was associated 
with waist-to-hip ratio (p = 0.01; r = 0.273); this and RBP-4 was correlated with office-based diastolic BP (r2 = 0.12).
Conclusion. Although relatively healthy, obese women present higher BP than lean. Anthropometrics, IR, and 
fasting glucose all influence BP in obesity; additionally, IR is involved in non-dipping. No strong correlation exists 
between BP/dipping and subclinical inflammation in either group of women.
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Introduction
Obesity is frequently referred to as an independent 
risk factor for high blood pressure and hypertension 
is very prevalent among obese people [1]. Compared 
to lean individuals, the National Health and Nutri-
tion Examination Survey III Study showed that the 
odds ratio for the presence of hypertension was 1.7 
for overweight, 2.6 for class I obesity, 3.7 for class II 
obesity and 4.8 for class III obesity [2]. Being both 
obesity and hypertension independent cardiovascular 
risk factors, obese hypertensive patients represent 
very high-risk individuals [3]. In the presence of 
excessive fat mass, the dysfunctional adipose tissue 
produces higher levels of adipokines that may inter-
fere at several steps of blood pressure control [4–7]. 
On the other hand adiponectin, an adipokine with 
reported beneficial effects on blood pressure lower-
ing, is synthesized at lower levels [8–10]. Moreover, 
obesity is associated with a hyperactivation of the 
sympathetic nervous system, which contributes both 
to an increase in blood pressure and to the blockade 
of the normal nocturnal fall in blood pressure [5, 
11–13]. The aim of this study was to compare classic 
office-based and 24h mean blood pressure and its cir-
cadian pattern between obese otherwise healthy and 
lean women without known history of hypertension. 
Secondarily, we aimed to study correlations of blood 
pressure, determined by the two methods, with in-
sulin resistance, markers of subclinical inflammation 
and early atherosclerosis in each group of women.
Material and methods
Subjects
The obese group consisted in 107 obese Caucasian 
premenopausal women who attended the obesi-
ty outpatient clinic at the Curry Cabral Hospital 
— C.H.L.C. (Lisbon, Portugal). Their age ranged 
from 18 to 50 years old and their body mass index 
(BMI) was ≥ 30 kg/m2. All of them referred less 
than 10% variation on their body weight in the 
previous year.
The control group consisted in 88 healthy Cauca-
sian premenopausal women, who either attended to 
a routine health check or belonged to the health care 
staff of Curry Cabral Hospital — C.H.L.C. They were 
aged from 18 to 50 years old, body mass index (BMI) 
from 18,5 to 24,9 kg/m2, and referring less than 10% 
variation on their body weight in the previous year. 
No woman was pregnant or had been pregnant in 
the precedent 12 months. We considered only wom-
en without previous diagnosis of any acute/chron-
ic health conditions (except obesity for the obese 
group), namely previous diagnosis of hypertension. 
No woman was on any pharmacological regimen 
(except for oral contraceptives) or took any sporadic 
drug in the previous 7 days. 
The study was conducted following the approval 
of the institutional scientific and ethical boards ac-
cordingly to the standards of the Declaration of Hel-
sinki. Additionally, an informed consent was signed 
by all participants.
Clinical evaluation
Each woman was characterized for total body weight, 
BMI, waist and hip circumferences, and waist-to-hip 
ratio. The total body fat mass (absolute and percent-
age of body weight) was assessed by bioelectrical 
impedance (Tanita TBF-300A®, Tanita Europe B.V., 
Hoofddorp, The Netherlands). 
Office-based blood pressure was assessed by the 
mean value of 2 determinations at the left arm, in the 
standard recommended conditions with a 5 minutes 
interval, using an electronic device with appropriated 
sized cuffs (CASMED® 740 monitor, CAS Medical 
Systems Inc, Branford, CT, USA). Women were clas-
sified as hypertensive if the mean values were ≥ 140 
mm Hg for systolic or ≥ 90 mm Hg for diastolic 
blood pressure.
ABPM was performed during a 24 h period, 
in a regular day, with registrations every 30 min-
utes during daytime (from 07:00 am to 11:00 pm) 
and every hour for the night-time (from 11:00 
pm to 07:00 am) with a portable electronic device 
(SpaceLabs 90207® monitor, SpaceLabs Healthcare, 
Issaquah, WA, USA) and appropriated sized cuffs. 
The device established the mean values of systolic 
and diastolic blood pressure for daytime, night-time 
and the overall 24h period. Women were classified as 
hypertensive if mean values were ≥ 130/80 mm Hg 
for the overall 24h, ≥ 135/85 mm Hg for the daytime 
or ≥ 120/70 mm Hg for the night-time periods ac-
cordingly to the European Society of Hypertension 
and European Society of Cardiology criteria [11]. 
They were considered as dippers if a ≥ 10% decrease 
in mean night-time blood pressure occurred com-
pared to mean daytime blood pressure.
Women answered a small questionnaire regard-
ing smoking status, use of oral contraceptives and 
the existence of diagnosed hypertension among first 
degree relatives. 
Blood sample collection and measurements
After a period of 10h fasting, a venous blood sample 
was collected from obese and lean women for as-
sessment of glucose, insulin, triglycerides, interleu-
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kin 6 (IL-6), tumor necrosis factor alpha (TNF-a), 
high-sensitivity C-reactive protein (hs-CRP), 
retinol-binding protein 4 (RBP-4), leptin, adipo-
nectin, resistin, monocyte chemoattractant pro-
tein 1 (MCP-1), intercellular adhesion molecule 1 
(ICAM-1), and vascular-cellular adhesion molecule 1 
(VCAM-1). Additionally, a classic 75 g oral glucose 
tolerance test was performed with blood samples 
collected after 30, 60, 90, and 120 minutes for the 
assessment of glucose and insulin. Serum samples 
were obtained by low-speed centrifugation, stored 
at a –80∞C ultra-freezer, and thawed just before each 
assay.
Glucose and triglycerides were determined by 
automated chemistry analyzer (Vitros® 5,1 FS 
Chemistry System, Ortho-Clinical Diagnosis Inc, 
Rochester, NY, USA) and hs-CRP concentration 
by a nephelometer system using CardioPhase® 
hsCRP assay (Siemens Healthcare Diagnostics Inc, 
Tarrytown, NY, USA). Leptinemia was assessed 
by radioimmunoassay technique (EMD Millipore 
Corporation, Billerica, MA, USA). Insulinemia 
was determined by a chemiluminescent immu-
nometric technique (IMMULITE® 2000 Immu-
noassay System, Siemens Healthcare Diagnostics 
Inc, Tarrytown, NY, USA). Serum IL-6, TNF-a, 
RBP-4, adiponectin, resistin, MCP-1, ICAM-1, 
and VCAM-1 concentrations were all measured by 
enzyme-linked immunosorbent assay following the 
manufacturer’s instructions (R&D Systems Inc., 
Minneapolis, MN, USA). Insulin resistance/sensi-
tivity was assessed by the application of four math-
ematical equations as follows:
• homeostasis model assessment of insulin resis-
tance (HOMA-IR) using the formula: fasting in-
sulin in μU/mL × fasting glucose in mg/dL/405; 
• quantitative insulin sensitivity check in-
dex (QUICKI): 1/[log(fasting insulin in 
μU/mL) + log(fasting glucose in mg/dL)]; 
• McAuley index (for assessment of insulin sen-
sitivity): exp[2.63 – 0.28 × log(fasting insulin 
in μU/mL – 0.31 × log(fasting triglycerides in 
mg/dl/87.72]; 
• Matsuda formula (also an index of insulin sensitiv-
ity): 10.000/SqRt[fasting insulin in μU/mL × fast-
ing glucose in mg/dL × mean (insulin at 0, 30, 
60, 90, and 120 min in μU/mL) × mean (glucose 
at 0, 30, 60, 90, and 120 min in mg/dL].
Statistical analysis
Data are reported as mean ± SD. Comparisons be-
tween groups were made by t-Student test. The in-
teractions between non-continuous parameters were 
analyzed by c2 test.
Simple associations were tested by Spearman r test 
and multiple regression analysis was carried out by 
the use of a forward stepwise model. A p value < 0.05 
was considered statistically significant. All determi-
nations were performed using SPSS software, version 
18.0 (IBM Corporation, Armonk, NY, USA).
Results
The characterization of obese and lean groups is de-
picted in Table 1. In the obese group, office-based 
systolic blood pressure was significantly correlated 
to systolic blood pressure values obtained by ABPM 
in daytime (p < 0.001; r = 0.539), night-time 
(p < 0.001; r = 0.386) and 24h period (p < 0.001; 
r = 0.561). Identical results were observed between 
mean diastolic blood pressure at the office and in 
Table 1. Characteristics of lean and obese women (mean ± SD)
Lean women Obese women p value
N 88 107
Age (years) 33.8 ± 8.4 34.5 ± 8.3 0.561
BMI [kg/m2] 21.5 ± 1.7 43.5 ± 7.5  < 0.001
Total body weight [kg] 56.0 ± 5.3 111.2 ± 20.8  < 0.001
Total body fat [kg] 14.2 ± 3.6 53.7 ± 14.5  < 0.001
Percentage of body fat (%) 25.0 ± 4.7 47.7 ± 5.1  < 0.001
Waist circumference [cm] 71.9 ± 6.0 117.3 ± 14.3  < 0.001
Hip circumference [cm] 97.6 ± 4.6 134.0 ± 12.6  < 0.001
Waist-to-hip ratio 0.74 ± 0.05 0.88 ± 0.08  < 0.001
Office systolic BP [mm Hg] 108.6 ± 12.1 124.7 ± 16.3  < 0.001
Office diastolic BP [mm Hg] 69.3 ± 9.7 79.5 ± 10.3  < 0.001
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ABPM in daytime (p < 0.001; r = 0.717), night-time 
(p = 0.002; r = 0.295) and 24h period (p < 0.001; 
r = 0.43). Also in obese women, there was a signifi-
cant inverse association of age with insulin resistance 
determined by HOMA-IR (p = 0.042; r = –0.197) 
and a trend for the inverse correlation with BMI 
(p = 0.056; r = –0.186); age was directly associ-
ated with all insulin sensitivity indexes: QUICKI 
(p = 0.009; r = 0.253), McAuley index (p = 0.007; 
r = 0.261), and Matsuda formula (p = 0.01; 
r = 0.248).
Less strong correlations were observed in the lean 
women between office-based systolic blood pres-
sure and systolic blood pressure by ABPM in day-
time (p = 0.001; r = 0.359), night-time (p = 0.015; 
r = 0.26) and 24h period (p = 0.002; r = 0.327). The 
same was observed concerning association of diastol-
ic office-based blood pressure and diastolic ABPM 
mean values in daytime (p = 0.009; r = 0.278), 
night-time (p = 0.013; r = 0.264) and 24h (p = 0.015; 
r = 0.258).
For both groups of women, the association be-
tween office-based blood pressure and 24h values 
in ABPM for systolic and diastolic blood pressure is 
exposed graphically in Figures 1 and 2, respectively.
Hypertension based on office measurements of 
blood pressure was more prevalent among obese 
women (Tab. 2), but that difference was not observed 
on ambulatory blood pressure monitoring (Tab. 3). 
Likewise, no difference between obese and lean groups 
was observed if we considered ABPM criteria for hy-
pertension in daytime (16.8% vs. 15.9%), night-time 
Table 1. Characteristics of lean and obese women (mean ± SD)
Lean women Obese women p value
ABPM systolic BP in 24h [mm Hg] 115.9 ± 9.6 121.0 ± 9.1  < 0.001
ABPM diastolic BP in 24h [mm Hg] 72.5 ± 7.2 72.6 ± 6.7 0.889
ABPM systolic BP in daytime [mm Hg] 119.2 ± 9.6 124.0 ± 9.7 0.001
ABPM diastolic BP in daytime [mm Hg] 75.9 ± 7.2 75.9 ± 7.5 0.973
ABPM systolic BP in night-time [mm Hg] 106.6 ± 10.6 112.4 ± 11.0  < 0.001
ABPM diastolic BP in night-time [mm Hg] 62.7 ± 7.6 63.6 ± 8.2 0.447
Fasting glucose [mg/dL] 81.0 ± 7.2 93.3 ± 29.2  < 0.001
Fasting insulin [μUI/mL] 5.9 ± 3.8 17.7 ± 11.4  < 0.001
Triglycerides [mg/dL] 79.8 ± 29.7 120.6 ± 78.3  < 0.001
Interleukin-6 [pg/mL] 1.39 ± 1.33 2.38 ± 1.66  < 0.001
TNF-a [pg/mL] 1.31 ± 0.81 1.38 ± 0.89 0.579
High-sensitivity C reactive protein [mg/dL] 0.22 ± 0.31 0.96 ± 0.76  < 0.001
RBP-4 [ng/mL] 41.3 ± 12.5 34.2 ± 16.4 0.001
Leptin [ng/mL] 10.5 ± 5.8 36.8 ± 14.9  < 0.001
Adiponectin [μg/mL] 12.3 ± 5.1 6.9 ± 3.3  < 0.001
Resistin [ng/mL] 19.2 ± 10.7 19.2 ± 9.6 0.99
MCP-1 [pg/mL] 324.7 ± 102.2 374.5 ± 129.6 0.003
ICAM-1 [ng/mL] 228.1 ± 54.2 245.8 ± 72.8 0.061
VCAM-1 [ng/mL] 506.7 ± 182.6 496.9 ± 186.1 0.714
HOMA-IR 1.18 ± 0.76 4.31 ± 3.56  < 0.001
QUICKI 0.17 ± 0.02 0.14 ± 0.01  < 0.001
McAuley index 9.50 ± 1.96 6.4 ± 1.7  < 0.001
Matsuda formula ND 3.92 ± 2.79 –
Women on oral contraceptives (%) 50.0 (44/88) 46.7 (50/107) 0.649
Current smokers (%) 35.2 (31/88) 12.1 (13/107)  < 0.001
Diagnosed hypertension in first degree relatives (%) 55.7 (44/79)* 54.1 (46/85)* 0.839
ND — not determined; BMI — body mass index; ABPM — ambulatory blood pressure monitoring; TNF-a — tumor necrosis factor alpha; hs-CRP — high-sensitivity C reactive protein RBP-4 — retinol-binding protein 
4; MCP-1 — monocyte chemoattractant protein 1; ICAM-1 — intercellular adhesion molecule 1; VCAM-1 — vascular-cellular adhesion molecule 1; HOMA-IR — homeostasis model assessment of insulin resistance; 
QUICKI — quantitative insulin sensitivity check index 
*Data concerning to the presence/absence of diagnosed hypertension in first degree relatives could not be obtained in 9 lean and in 22 obese women
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(31.1% vs. 27.6%) and 24h (19.6% vs. 18.2%) pe-
riods separately. When comparing those diagnosed 
for hypertension by office-based measurements with 
those based on ABPM, different populations were 
found (Tab. 4). That was also true if we compared 
office-based hypertensive women with those with 
daytime (p < 0.001), night-time (p = 0.012) and 24h 
(p < 0.001) criteria for hypertension.
Non-dipper pattern of blood pressure variation 
was more prevalent in obese than in lean women 
Figure 1. Correlation of mean systolic office-based blood pressu-
re and mean values in 24 h ambulatory blood pressure monito-
ring, in obese and normal-weight women
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Figure 2. Correlation of mean diastolic office-based blood pressu-
re and mean values in 24 h ambulatory blood pressure monito-
ring, in obese and normal-weight women
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Table 2. Obese and lean women meeting criteria for hypertension by office-based blood pressure
p < 0.001
Office-based blood pressure criteria for hypertension
Total
Yes No
Group
Obese women 28(26.2%)
79
(73.8%)
107
(100%)
Lean women 3(3.4%)
85
(96.6%)
88
(100%)
Total 31(15.9%)
164
(84.1%)
195
(100%)
Table 3. Obese and lean women meeting criteria for hypertension by ambulatory blood pressure monitoring
p = 0.199
Ambulatory blood pressure monitoring criteria 
for hypertension Total
Yes No
Group
Obese women 41(38.3%)
66
(61.7%)
107
(100%)
Lean women 26(29.5%)
62
(70.5%)
88
(100%)
Total 67(34.4%)
128
(65.6%)
195
(100%)
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and diastolic blood pressure in daytime (p = 0.013; 
r = 0.269) and 24h period (p = 0.013; r = 0.267) 
ABPM. Systolic office-based blood pressure was as-
sociated with waist-to-hip ratio (p = 0.01; r = 0.273); 
waist-to-hip ratio and RBP-4 circulating levels were 
independently associated with diastolic office-based 
blood pressure (r2 = 0.12). In this group of women, 
no association was found for the dipping phenom-
enon with any of the parameters considered in this 
study.
Discussion
As classically described, obesity is associated with 
high blood pressure [1, 2]. That was also shown in 
this study for office-based systolic and diastolic blood 
pressure and for systolic blood pressure in all periods 
considered in ABPM. Although a high correlation 
was present between office-based and ABPM, it was 
found a significant difference in hypertension preva-
lence between obese and lean women for office-based 
criteria but not for ABPM criteria. In concordance to 
these data, we confirmed that the group of women di-
agnosed with hypertension by one criterion does not 
fit in the hypertension definition by the other. For the 
definition of daytime and night-time we considered 
fixed schedules. One possibility for the dissimilarity 
between criteria could be the fact that some women 
had daytime-like activities over 11:00 pm or before 
07:00 am. If it would be the case, mean night-time 
blood pressure values would be expected to increase 
(39.6% vs. 24.1%; p = 0.022). Considering each 
group of women, the prevalence of non-dippers was 
lower in those who fitted the criteria for night-time 
hypertension than in those who did not, either in 
obese (p = 0.001) or in lean women (p = 0.018).
In obese women several direct correlations exist 
between blood pressure, insulin resistance and some 
markers of subclinical inflammation or atherogen-
esis. Moreover, some particular inverse correlations 
were present between some of those parameters and 
the degree of nocturnal fall in blood pressure. By 
a stepwise multiple regression analysis HOMA-IR 
and body fat percentage were found to be inde-
pendently associated to 24 h (r2 = 0.176) and day-
time (r2 = 0.111) systolic blood pressure; HOMA-IR 
and waist circumference were independently as-
sociated with night-time systolic blood pressure 
(r2 = 0.202). Fasting glucose was associated with day-
time (p = 0.039; r = 0.199) and 24h diastolic blood 
pressure (p = 0.008; r = 0.256). Night-time dia-
stolic blood pressure was correlated with HOMA-IR 
(p = 0.003; r = 0.286) and QUICKI (p = 0.017; 
r = –0.231). By a stepwise multiple regression analy-
sis, it was shown that TNF-a levels (inversely), age 
and QUICKI (directly) were all independently cor-
related with the dipping phenomenon (r2 = 0.172). 
Adiponectin circulating levels (inversely), age, BMI, 
and fasting glucose (directly) were all independent-
ly correlated to systolic (r2 = 0.226) and diastolic 
(r2 = 0.215) office-based blood pressure.
By contrast, among lean women an independent 
association exists between MCP-1 circulating levels 
Table 4. Comparison of hypertensive groups by office-based and ambulatory blood pressure monitoring considering only obese women 
and both groups together
Ambulatory blood pressure monitoring criteria 
for hypertension Total
Yes No
Obese women (p = 0.005)
Office-based blood  
pressure criteria  
for hypertension
Yes 17(15.9%)
11
(10.3%)
28
(26.2%)
No 24(22.4%)
55
(51.4%)
79
(73.8%)
Total 41(38.3%)
66
(61.7%)
107
(100%)
Both groups together (p = 0.001)
Office-based blood  
pressure criteria  
for hypertension
Yes 19(9.8%)
12
(6.1%)
31
(15.9%)
No 48(24.6%)
116
(59.5%)
164
(84.1%)
Total 67(34.4%)
128
(65.6%)
195
(100%)
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leading to a higher prevalence of night-time hyper-
tension and exaggerating hypertension rates based 
in ABPM [15]. Nevertheless, that explanation does 
not appear to fit; if we compared women with of-
fice-based hypertension with those with hypertension 
criteria based on daytime, the difference was even 
greater (p < 0.001) than if we compared with those 
with night-time hypertension (p = 0.012).
All the factors that were independently associated 
with office-based blood pressure values in obese wom-
en (i.e. age, BMI, fasting glucose, and adiponectin), 
and that explains more than one fifth of its variation, 
are in line with previous reports in the literature [5, 
16–18]. Also based on ABPM, it was shown a direct 
association of systolic blood pressure with anthropo-
metrics. The net association between fasting glucose 
levels and diastolic blood pressure is concordant with 
the close relationship that exists between hyperten-
sion and glucose intolerance states. Hypertension is 
more prevalent in individuals with type 2 diabetes 
and intermediate hyperglycemia and these conditions 
are more prevalent among individuals diagnosed with 
hypertension [17–19]. Independently from anthro-
pometrics, insulin resistance was also directly associat-
ed with blood pressure values in obese women. This is 
in line with the evidence of insulin resistance per se as 
a contributing factor for hypertension. There are sev-
eral mechanistic explanations for the association be-
tween insulin resistance and blood pressure increase; 
one of those mechanisms involves sympathetic activa-
tion. [20]. The greater sympathetic activity in insulin 
resistant women would explain the higher night-time 
blood pressure values and the non-dipping pattern 
observed. Non-dippers have also been reported to be 
more prevalent in conditions characterized by insulin 
resistance [21]. 
The inverse independent association of TNF-a 
with the dipping status would be expected in the 
context of a higher atherogenic-related subclinical in-
flammation state [22]. Assuming non-dipper status as 
a cardiovascular risk factor it would be logical to find 
higher levels of several atherogenic markers, but it 
was not the case. Another possible explanation for the 
inverse association of TNF-a with dipping phenom-
enon could be through induction of insulin resistance 
[23]. Nevertheless, that association is independent of 
insulin sensitivity and no association could be found 
between TNF-a and insulin resistance indexes in this 
study. On the other hand, TNF-a itself could have 
some direct effect on vasculature inducing endothelial 
dysfunction and a decrease in nitric oxide synthesis as 
previously demonstrated in rats [24, 25]. 
Aging is characterized by an increase in sympa-
thetic activity [26]. However, in this study it was 
found an inverse association between age and dip-
ping in obese women. It is true that there was a trend 
for the inverse correlation of age with BMI and that 
age was directly associated with insulin sensitivity. 
Nevertheless, the association of age with the dipping 
status was independent of those two parameters. 
For the inclusion criteria only women without any 
known health condition (other than obesity) were 
accepted. The age ranged from 18 to 50 years old 
but it was especially difficult to find obese women 
above the age of 35 (and a more prolonged history of 
obesity) with no known comorbidities. Perhaps those 
older obese women selected belong to the so-called 
relatively benign obesity or metabolically healthy but 
obese individuals, i.e. those with obesity but without 
the metabolic and cardiovascular risks as expected for 
the degree of excessive body fat [27, 28].
Opposite to the obese group, in lean women all 
the above associations were missing. That could be 
the case because most of the parameters shown to 
be associated with blood pressure parameters in the 
obese group were lower in lean women. Thus there 
was still no deleterious involvement on blood pres-
sure control. One exception was anthropometry, 
confirming that it exerts an effect on blood pressure 
even in the absence of excessive body fat mass.
Although an association exists between mean 
blood pressure levels in ABPM and those obtained by 
standard measurement in the office setting, whether 
we use one or the other for the diagnosis of hyperten-
sion we are identifying different groups of women. 
In obese women, anthropometrics and insulin re-
sistance are main determinants of blood pressure 
in ABPM. Age, anthropometrics, fasting glucose, 
and adiponectin circulating levels all influence of-
fice-based blood pressure levels, explaining a little 
more than 20% of it. On the other hand, age, insulin 
resistance and TNF-a levels are all independent de-
terminants of blood pressure fall during night-time. 
Even though assuming a lower cardiovascular risk 
compared to the classic obesity, metabolically healthy 
but obese women present higher blood pressure (es-
sentially systolic blood pressure). However, no strong 
correlation exists between blood pressure or the dip-
ping phenomenon and subclinical inflammation or 
markers of atherosclerosis activity either in lean or in 
metabolically healthy but obese women.
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